EUVIMEDEUVIMED entdecken
Crossref

Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway

Aqun Li, Tong Nie, Xin Wang, Jun Ma

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Aqun Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Hesperidin, Hepatocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: The annual rise in the worldwide incidence of nonalcoholic fatty liver disease (NAFLD) continues; however, there remains a lack of safe and well-proven specific pharmacological treatments for this condition. Hesperidin (HDN), a citrus-derived flavonoid, displays antioxidant properties, and research indicates its capacity to mitigate NAFLD. METHODS: This study developed both in vivo and in vitro high-fat models using high-fat diet (HFD)-induced mice and palmitoleic acid (PO)-stimulated Alpha Mouse Liver 12 (AML12) cells, respectively. We investigated the protective mechanisms of HDN against HFD-induced NAFLD through a comprehensive set of experimental approaches, including pathological examination, RNA sequencing, Western Blot, immunofluorescence (IF), flow cytometry, acridine orange/ethidium bromide (AO/EB) dyeing, molecular docking, co-immunoprecipitation (Co-IP), and Oil Red O staining. Additionally, siRNA-mediated gene silencing and pharmacological treatment with 740 YP were used to validate the in vitro findings. RESULTS: Biochemical analysis demonstrated that HDN intervention effectively reduced lipid accumulation in NAFLD. Bioinformatics analysis identified vascular endothelial growth factor A (VEGFA) as a key mediator through which HDN exerts its protective effects against NAFLD. Western Blot and immunofluorescence (IF) analyses revealed that HDN significantly alleviated cell cycle dysregulation, apoptosis, and necroptosis in NAFLD mice. Molecular docking and Co-IP results showed that HDN activates the VEGFA-PI3K/AKT signaling pathway to ameliorate NAFLD. CONCLUSION: HDN alleviates NAFLD by restoring VEGFA-PI3K/AKT signaling, thereby stabilizing the cell cycle and suppressing apoptosis and necroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHesperidinHepatocytesAnimalsProto-Oncogene Proteins c-aktApoptosisMiceVascular Endothelial Growth Factor APhosphatidylinositol 3-KinasesSignal TransductionMaleDiet, High-FatNecroptosisMice, Inbred C57BLDisease Models, AnimalCell LineCell CycleHumansLiver

Stichwörter der Autor:innen

ApoptosisHesperidinNAFLDPI3K/AKTVEGFA

Substanzen

HesperidinProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor APhosphatidylinositol 3-Kinasesvascular endothelial growth factor A, mouse

Autor:innen und Institutionen

  • College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China.
  • College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, PR China; Heilongjiang Provincial Key Laboratory of Pathogenic Mechanism for Animal Disease and Comparative Medicine, Harbin 150030, PR C…

Zitieren

APA

Li, A., Nie, T., Wang, X., & Ma, J. (2025). Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115304

Vancouver

Li A, Nie T, Wang X, Ma J. Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115304

BibTeX
@article{Li2025,
  author = {Li, Aqun and Nie, Tong and Wang, Xin and Ma, Jun},
  title = {Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K/AKT pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115304}
}
Kostenlos starten →